[1] Shioko K, Tomio K, Mcbride OW, et al. Human thyroid peroxidace:complete cDNA and protein sequende, chromosome mapping, and identification of two alternately spliced mRNAs[J]. Proc Natl Acad Sci USA, 1987, 84(16):5555-5559.
[2] Niccoli P, Fayadat L, Panneels V, et al. Human thyroperoxidase in its alternatively spliced form (TPO2) is enzymatically inactive and exhibits changes in intracellular processing and trafficking[J]. J Biol Chem, 1997, 272(47):29487-29492.
[3] Marc A, Gilbert V, Daniel C, et al. Functional study of the human thyroid perexidase gene promoter[J]. Eur J Biochem, 1992, 203(3) 467-473.
[4] Lourdes O, Pedro AB, Mariastella Z, et al. The interaction between the forkhead thyroid tran-sciption factor TTF-2 and the constitutive factor CTF/NT-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription[J]. J Biol Chem, 1999, 274(21):15213-15221.
[5] Mariastella Z, Helen FL, Dimitri P, et al. Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters[J]. Mol Cell Biol, 1992, 12(9):4230-4241.
[6] Rossana DL, Stefania M, Enrico Z, et al. Role for p300 in Pax8 induction of thyroperoxidase gene expression[J]. J Biol Chem, 2000, 275(44):34100-34105.
[7] Claudio E, Stetania M, Adolfo S, et al. Pax8 activates the enhancer of the human thyroperoxi-dase gene[J]. Biochem J, 1998, 331(1):37-40.
[8] Gerard CM, Lefort A, Christophe D, et al. Distinct transcriptional effects of cAMP on 2 thyroid specific genes:thyroperoxidase and thyroglobulin[J]. Horm Metab Res buppl, 1990, 23:38-43.
[9] Penel C, Gruffat D, Alquier C, et al. Thyrotropin chronically regulates the pool of thyropero-xidase and its intra-cellular distribution:a quantitative confocal microscopic study[J]. J Cell Physiol, 1998, 174(2):160-169.
[10] Napolitano G, Montani V, Giuliani C, et al. Transforming growth factor-betal down-regulation of major histo-compatibility complex class I in thyrocytes:coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors[J]. Mol Endocrinol, 2000, 14(4):486-505.
[11] Miyazaki A, Shimura H, Endo T, et al. Tumor necrosis factor-alpha and interferon-gamma suppress both gene expression and deoxyribonucleic acid-binding of TTF-2 in FRTL-5 cells[J]. Endocrinology, 1999, 140(9):4214-4220.
[12] Uyttersprot N, Pelgrims N, Carrasco N, et al. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid[J]. Mol Cell Endocrinol, 1997, 131(2):195-203.
[13] Ortia L, Zannini M, Di-Lauro R, et al. Transcriptional contral of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and insulin-like growth factor 1[J]. J Biol Chem, 1997, 272(37):23334-23339.
[14] Da-Costa VM, Moreira DG, Rosenthal D, et al. Thyroid function and aging:gender-related differences[J]. J Endocrinol, 2001, 171(1):193-198.
[15] Armengol MP, Juan M, Lucas MA, et al. Thyroid autoimmune disease:demon-stration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers[J]. Am J Pathol, 2001, 159(3):861-873.
[16] Niedziela M, Korman E. Severe hypothyroidism due to autoimmune atrophic thyroiditis-predicted target height and a plausible mechanism for sexual precocity[J]. J Pediatr Endocrinol Metab, 2001, 14(7):901-907.
[17] Deleu S, Allory Y, Radulescu A, et al. Characterization of autonomous thyroid adenoma:metabolism, gene expression, and pathology[J]. Thyroid, 2000, 10(2):131-140.
[18] Ros P, Rossi DL, Acebron A, et al. Thyroid-specific gene expression in the multi-step process of thyroid careino-genesis[J]. Biochimie, 1999, 81(4):389-396.
[19] Franke WG, Zophel K, Wunderlieh GR, et al. Thyropemxidase:a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study[J]. Cancer Detect Prey, 2000, 24(6):524-530.
[20] Geraldo M, Maria J, Cecilia L, et al. Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene[J]. J Clin Endoerinol Metab, 1998, 83(11):4162-4166.
[21] Haberkorn U, Altmann A, Jiang S, et al. Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene[J]. Eur J Nucl Med, 2001, 28(5):633-638.
[22] Huang M, Raj K, Takahiko K, et al. Ectopic expression of the thyroperoxidase gene aug-ments radioiodide uptake and retention mediated by the sodium iodide symporter in nonsmall cell lung cancer[J]. Cancer Gene Therapy, 2001, 8(8):612-618.
[23] Boland A, Magnon C, Filetti S, et al. Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers[J]. Thyroid, 2002, 12(1):19-26.